Franssila K - Search Results

1

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Niskanen E, Blomqvist C, Franssila K, Hietanen P, Wasenius VM. Niskanen E, et al. Among authors: franssila k. Br J Cancer. 1997;76(7):917-22. doi: 10.1038/bjc.1997.484. Br J Cancer. 1997. PMID: 9328152 Free PMC article.

2

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer.

Sjöström J, Collan J, von Boguslawski K, Franssila K, Bengtsson NO, Mjaaland I, Malmström P, Østenstad B, Wist E, Valvere V, Bergh J, Skiöld-Petterson D, Saksela E, Blomqvist C. Sjöström J, et al. Among authors: franssila k. Eur J Cancer. 2002 Mar;38(4):535-42. doi: 10.1016/s0959-8049(01)00403-8. Eur J Cancer. 2002. PMID: 11872346 Clinical Trial.

3

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

Muhonen T, Pyrhönen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K, Kangas L. Muhonen T, et al. Among authors: franssila k. Br J Cancer. 1992 Sep;66(3):528-32. doi: 10.1038/bjc.1992.307. Br J Cancer. 1992. PMID: 1520590 Free PMC article.

4

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

Hietanen P, Blomqvist C, Wasenius VM, Niskanen E, Franssila K, Nordling S. Hietanen P, et al. Among authors: franssila k. Br J Cancer. 1995 May;71(5):1029-32. doi: 10.1038/bjc.1995.198. Br J Cancer. 1995. PMID: 7734295 Free PMC article. Clinical Trial.

5

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.

Sjöström J, Krajewski S, Franssila K, Niskanen E, Wasenius VM, Nordling S, Reed JC, Blomqvist C. Sjöström J, et al. Among authors: franssila k. Br J Cancer. 1998 Sep;78(6):812-5. doi: 10.1038/bjc.1998.584. Br J Cancer. 1998. PMID: 9743306 Free PMC article. Clinical Trial.

6

Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.

Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H. Wasenius VM, et al. Among authors: franssila k. Clin Cancer Res. 2003 Jan;9(1):68-75. Clin Cancer Res. 2003. PMID: 12538453

7

Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Hemmer S, Wasenius VM, Knuutila S, Joensuu H, Franssila K. Hemmer S, et al. Among authors: franssila k. Br J Cancer. 1998 Oct;78(8):1012-7. doi: 10.1038/bjc.1998.620. Br J Cancer. 1998. PMID: 9792143 Free PMC article.

8

DNA copy number changes in thyroid carcinoma.

Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H. Hemmer S, et al. Among authors: franssila k. Am J Pathol. 1999 May;154(5):1539-47. doi: 10.1016/S0002-9440(10)65407-7. Am J Pathol. 1999. PMID: 10329606 Free PMC article.

9

Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.

Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC. Krajewski S, et al. Among authors: franssila k. Cancer Res. 1995 Oct 1;55(19):4471-8. Cancer Res. 1995. PMID: 7671262

10

Mouse subrenal capsule assay chemosensitivity and DNA flow cytometry parameters of human melanoma metastases.

Muhonen T, Pyrhönen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K, Kangas L. Muhonen T, et al. Among authors: franssila k. Acta Oncol. 1994;33(4):431-7. doi: 10.3109/02841869409098440. Acta Oncol. 1994. PMID: 8018377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page